Sodium Valproate Inhibits the Growth of Human Cholangiocarcinoma In Vitro and In Vivo
Figure 8
The effect of sodium valproate treatment on cholangiocarcinoma xenografts. (a) Tumor xenografts were established in mice by implanting TFK-1 cells on the upper-right flank. Animals were randomly divided into 2 groups and injected through i.p. with vehicle (control group) or sodium valproate (300 mg/kg, every day) for 2 weeks. Values were presented as mean ± SD. compared with the control. (b) Representative tumor tissue excised from control (left) and treated groups (right).
